May 19, 2021 Dr. Samantha Pattenden, Associate Professor within the Division of Chemical Biology and Medicinal Chemistry, and Director of Applied Epigenetic Screening Technologies in the Center for Integrative Chemical Biology and Drug Discovery, and Dr. Ian Davis, Professor, Pediatrics … Read more
May 14, 2021 Dr. Xiaodong Wang, a Research Professor within the Center for Integrative Chemical Biology and Drug Discovery, and its Director of Medicinal Chemistry was awarded over $1.5 million from NIH along with her collaborator, Douglas Graham, PhD of … Read more
Tops $2 million, supports small molecule research to identify new approaches to modulating drug target Brittany Jennings March 26, 2021 Each day, Stephen Frye, Ph.D., works to identify pharmacologic approaches to intervene in novel drug targets within stephen_fryethe human … Read more
Dr. Samantha Pattenden, Associate Professor, joined the CICBDD in 2010 as a Postdoctoral Research Associate and in 2015 was promoted to Assistant Professor, Director of Applied Epigenetic Screening Technologies. In 2017 she co-founded Triangle Biotechnology, Inc. with Dr. Paul Dayton … Read more
From Angela Kashuba, Dean, UNC Eshelman School of Pharmacy: I am delighted to announce that Ken Pearce, Ph.D., will become co-director of the Center for Integrative Chemical Biology and Drug Discovery on March 1. Ken brings a wealth of experience … Read more
This past fall, the Eshelman Institute for Innovation (EII) completed its 5th Annual Graduate Student and Postdoc Award cycle. Each year, the EII awards student/postdoc projects up to $25,000 in funding to advance novel and impactful research. For 2021, the … Read more
Dr. Dmitri Kireev joined the CICBDD in September, 2008 as Professor and Director of Computational Biophysics and Molecular Design (CBMD). The focus of the Dr. Kireev’s research is computational biophysics and computer-aided drug design. The Kireev lab develops and applies … Read more
